Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Just Reported Earnings, And Analysts Cut Their Target Price [Yahoo! Finance]
Maravai LifeSciences Holdings, Inc. - Class A common stock (MRVI)
Company Research
Source: Yahoo! Finance
It was a pretty negative result overall, with revenues of US$65m missing analyst predictions by 3.7%. Worse, the business reported a statutory loss of US$0.70 per share, much larger than the analysts had forecast prior to the result. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year. See our latest analysis for Maravai LifeSciences Holdings Following last week's earnings report, Maravai LifeSciences Holdings' 14 analysts are forecasting 2025 revenues to be US$274.6m, approximately in line with the last 12 months. Earnings are expected to improve, with Maravai LifeSciences Holdings forecast to report a statutory profit of US$0.14 per share. Before this earnings report, the analysts had been for
Show less
Read more
Impact Snapshot
Event Time:
MRVI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRVI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRVI alerts
High impacting Maravai LifeSciences Holdings, Inc. - Class A common stock news events
Weekly update
A roundup of the hottest topics
MRVI
News
- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.MarketBeat
- Maravai LifeSciences Announces November 2024 Investor Conference ScheduleGlobeNewswire
- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) had its price target lowered by analysts at Royal Bank of Canada from $17.00 to $13.00. They now have an "outperform" rating on the stock.MarketBeat
- Maravai LifeSciences (MRVI) Q3 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Maravai LifeSciences Holdings Inc (MRVI) Q3 2024 Earnings Call Highlights: Navigating ... [Yahoo! Finance]Yahoo! Finance
MRVI
Earnings
- 11/7/24 - Beat
MRVI
Sec Filings
- 11/14/24 - Form SC
- 11/14/24 - Form 4
- 11/13/24 - Form SC
- MRVI's page on the SEC website